Higher‐dose heparin vs standard‐dose heparin
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery 2022 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 597 participantsLow
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
It is very uncertain whether higher‐dose heparin changes PE compared with standard‐dose heparin (very low certainty).
It is very uncertain whether higher‐dose heparin changes DVT compared with standard‐dose heparin (very low certainty).
It is very uncertain whether higher‐dose heparin changes adverse events (thrombocytopenia) compared with standard‐dose heparin (very low certainty).
Heparin showed no clear difference in VTE compared with pentasaccharide (low certainty).
It is very uncertain whether heparin changes major bleeding compared with pentasaccharide (very low certainty).
It is very uncertain whether NPWT changes time to primary fascial closure of the abdomen compared with the Bogota bag (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether NPWT changes adverse events (fistulae formation) compared with the Bogota bag (very low certainty).
It is very uncertain whether NPWT changes all‐cause mortality compared with the Bogota bag (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether suprasorb CNP system changes proportion of participants with successful primary fascial closure… compared with the ABThera system (very low certainty).
It is very uncertain whether suprasorb CNP system changes adverse events (fistulae formation) compared with the ABThera system (very low certainty).
It is very uncertain whether suprasorb CNP system changes all‐cause mortality compared with the ABThera system (very low certainty).
It is very uncertain whether probiotics changes occurrence of HAEC compared with placebo (very low certainty).
Probiotics showed no clear difference in severity of HAEC Â compared with placebo (low certainty).